Trial NCT02633293

View at ClinicalTrials.gov 
Org. Study IDs: RIN-PH-202

Last trial update was posted on 2022-12-02

MeSH Interventions

Treprostinil

MeSH Conditions

Emphysema Hypertension Hypertension, Pulmonary Lung Diseases Lung Diseases, Interstitial Pulmonary Fibrosis

Other Conditions

Combined Pulmonary Fibrosis and Emphysema Interstitial Lung Disease Pulmonary Hypertension

Stopping Reasons

Inhaled treprostinil became commercially available in the US following its approval for PH-ILD

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID